Literature DB >> 19896750

Gadolinium deposition in nephrogenic systemic fibrosis: an examination of tissue using synchrotron x-ray fluorescence spectroscopy.

Whitney A High1, James F Ranville2, Mariah Brown3, Tracy Punshon4, Antonio Lanzirotti5, Brian P Jackson6.   

Abstract

BACKGROUND: Nephrogenic systemic fibrosis is a fibrosing disorder associated with gadolinium (Gd)-based contrast agents dosed during renal insufficiency.
OBJECTIVE: In two patients, Gd deposition in tissue affected by nephrogenic systemic fibrosis was quantified using inductively coupled plasma mass spectrometry. The presence of Gd was confirmed and mapped using synchrotron x-ray fluorescence spectroscopy.
RESULTS: Affected skin and soft tissue from the lower extremity demonstrated 89 and 209 ppm (microg/g, dry weight, formalin fixed) in cases 1 and 2, respectively. In case 2, the same skin and soft tissue was retested after paraffin embedding, with the fat content removed by xylene washes, and this resulted in a measured value of 189 ppm (microg/g, dry weight, paraffin embedded). Synchrotron x-ray fluorescence spectroscopy confirmed Gd in the affected tissue of both cases, and provided high-sensitivity and high-resolution spatial mapping of Gd deposition. A gradient of Gd deposition in tissue correlated with fibrosis and cellularity. Gd deposited in periadnexal locations within the skin, including hair and eccrine ducts, where it colocalized to areas of high calcium and zinc content. LIMITATIONS: Because of the difficulty in obtaining synchrotron x-ray fluorescence spectroscopy scans, tissue from only two patients were mapped. A single control with kidney disease and gadolinium-based contrast agent exposure did not contain Gd.
CONCLUSIONS: Gd content on a gravimetric basis was impacted by processing that removed fat and altered the dry weight of the specimens. Gradients of Gd deposition in tissue corresponded to fibrosis and cellularity. Adnexal deposition of Gd correlated with areas of high calcium and zinc content.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19896750     DOI: 10.1016/j.jaad.2009.07.018

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  8 in total

Review 1.  Elemental and chemically specific X-ray fluorescence imaging of biological systems.

Authors:  M Jake Pushie; Ingrid J Pickering; Malgorzata Korbas; Mark J Hackett; Graham N George
Journal:  Chem Rev       Date:  2014-08-07       Impact factor: 60.622

Review 2.  Renal imaging in patients with renal impairment.

Authors:  Jason A Poff; Elizabeth M Hecht; Parvati Ramchandani
Journal:  Curr Urol Rep       Date:  2011-02       Impact factor: 3.092

3.  Gadolinium exposure disrupts iron homeostasis in cultured cells.

Authors:  Andrew J Ghio; Joleen M Soukup; Lisa A Dailey; Judy Richards; Zhongping Deng; Jerrold L Abraham
Journal:  J Biol Inorg Chem       Date:  2011-01-26       Impact factor: 3.358

4.  Synchrotron X-ray analyses demonstrate phosphate-bound gadolinium in skin in nephrogenic systemic fibrosis.

Authors:  S J George; S M Webb; J L Abraham; S P Cramer
Journal:  Br J Dermatol       Date:  2010-11       Impact factor: 9.302

5.  Impact of Kidney Function on CNS Gadolinium Deposition in Patients Receiving Repeated Doses of Gadobutrol.

Authors:  S Dogra; M J Borja; Y W Lui
Journal:  AJNR Am J Neuroradiol       Date:  2021-02-25       Impact factor: 3.825

6.  Gadolinium distribution in kidney tissue determined and quantified by micro synchrotron X-ray fluorescence.

Authors:  Wolf Osterode; Gerald Falkenberg; Heinz Regele
Journal:  Biometals       Date:  2021-01-23       Impact factor: 2.949

Review 7.  Gadolinium: pharmacokinetics and toxicity in humans and laboratory animals following contrast agent administration.

Authors:  Julie Davies; Petra Siebenhandl-Wolff; Francois Tranquart; Paul Jones; Paul Evans
Journal:  Arch Toxicol       Date:  2022-01-08       Impact factor: 5.153

8.  Detection and imaging of gadolinium accumulation in human bone tissue by micro- and submicro-XRF.

Authors:  Anna Turyanskaya; Mirjam Rauwolf; Vanessa Pichler; Rolf Simon; Manfred Burghammer; Oliver J L Fox; Kawal Sawhney; Jochen G Hofstaetter; Andreas Roschger; Paul Roschger; Peter Wobrauschek; Christina Streli
Journal:  Sci Rep       Date:  2020-04-14       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.